Watchlist Price Alert

Dyne Therapeutics Inc. (DYN)

NASDAQ: DYN · Real-Time Price · USD

13.81

-0.60 (-4.16%)

At close: Jun 16, 2025, 3:59 PM

Dyne Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	506M	1.37B
Cost of Revenue	n/a	2.46M	3.35M	1.09M	700K	271K	24K	2.93B	2.28B
Gross Profit	n/a	-2.46M	-3.35M	-1.09M	-700K	-271K	-24K	-2.43B	-915M
Operating Income	-343.89M	-242.16M	-170.96M	-150.03M	-58.65M	-13.83M	-4.79M	-412M	-640M
Interest Income	26.92M	7.64M	2.92M	742K	56K	290K	5K	n/a	n/a
Pretax Income	-317.42M	-235.94M	-168.1M	-149.29M	-59.44M	-14.86M	-4.81M	-538M	-1.29B
Net Income	-317.42M	-235.94M	-165.24M	-149.28M	-58.74M	-13.54M	-4.81M	76M	-1.24B
Selling & General & Admin	62.48M	31.4M	28.2M	28.72M	13.45M	2.79M	517K	189M	161M
Research & Development	281.41M	210.76M	142.76M	121.31M	45.2M	11.04M	4.28M	n/a	n/a
Other Expenses	n/a	n/a	2.86M	-8K	-790K	-1.32M	-21K	n/a	n/a
Operating Expenses	343.89M	242.16M	170.96M	150.03M	58.65M	13.83M	4.79M	189M	161M
Interest Expense	n/a	n/a	2.92M	n/a	396K	n/a	5K	616M	625M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	242.16M	170.96M	150.03M	58.65M	13.83M	4.79M	3.12B	2.44B
Income Tax Expense	n/a	n/a	-2.86M	-8K	-700K	-1.32M	-11K	-610M	-45M
Shares Outstanding (Basic)	94.14M	59.68M	51.98M	50.9M	14.4M	45.42M	10.32M	162M	129M
Shares Outstanding (Diluted)	94.14M	59.68M	51.98M	50.9M	14.4M	45.42M	10.32M	162M	129M
EPS (Basic)	-3.37	-3.95	-3.18	-2.93	-4.08	-0.3	-0.47	0.47	-9.61
EPS (Diluted)	-3.37	-3.95	-3.18	-2.93	-4.08	-0.3	-0.47	0.47	-9.61
EBITDA	-315.18M	-233.48M	-164.75M	-148.2M	-58.34M	-14.59M	-4.79M	949M	106M
EBIT	-317.42M	-235.94M	-168.1M	-149.29M	-59.04M	-14.86M	-4.81M	78M	-664M
Depreciation & Amortization	2.24M	2.46M	3.35M	1.09M	700K	271K	24K	867M	766M